Abiopharma

News list

Weakley Monica 🟢 acquired 631 shares (1 derivative) of AGNT, Inc. (AGNT) at $3.85 Transaction Date: Aug 31, 2026 | Filing ID: 000019

Full text

News bot Aug. 31, 2026, 11:30 p.m.
🔍 Weakley Monica (Executive)

Company: AGNT, Inc. (AGNT)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 631
Detailed Transactions and Holdings:
- Acquired 521 shares of Common Stock at $3.85 per share (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: false | shares_owned_after: 12,134.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 11 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: M | equity_swap_involved: false | shares_owned_after: 12,145.00 | transaction_form_type: 4 | Footnotes: F2
- Acquired 99 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: A | equity_swap_involved: false | shares_owned_after: 8,219.00 | transaction_form_type: 4 | Footnotes: F3, F4
Footnotes:
- F1: These shares were issued to the reporting person under AGNT, Inc.'s (the "Issuer") Agent Equity Program.
- F2: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Person.
- F3: The RSUs are scheduled to vest 100% on July 31, 2029, subject to the reporting person's continued service to the Issuer through the respective vesting date.
- F4: RSUs do not expire; they either vest or are canceled prior to the vesting date.